| Mr Jeffrey Linn Brooke, PA-C | |
|
800 Cordova St, Anchorage, AK 99501-3717 | |
| (907) 222-7612 | |
| Not Available |
| Full Name | Mr Jeffrey Linn Brooke |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 800 Cordova St, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235342759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 501 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jeffrey Linn Brooke, PA-C Po Box 1126, Mount Vernon, WA 98273-1126 Ph: (360) 293-6180 | Mr Jeffrey Linn Brooke, PA-C 800 Cordova St, Anchorage, AK 99501-3717 Ph: (907) 222-7612 |
News Archive
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
Scientists at Trinity College Dublin have made an important discovery concerning how fledgling cancer cells self-destruct, which has the potential of impacting on future cancer therapies.
Rush University Medical Center will be the first in Chicago and among the first hospitals in the nation to offer a promising new treatment for arterio-venous malformations (AVMs) following its approval by the FDA on July 21.
Campylobacter infection, one of the most common foodborne illnesses in the Western world, can also be spread through sexual contact, according to a new research discovery by an OU Hudson College of Public Health faculty member, working in conjunction with colleagues in Denmark.
Clementia Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation for palovarotene, the company's lead product candidate, for the treatment of fibrodysplasia ossificans progressiva (FOP).
› Verified 1 days ago
Amanda Loomis, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 550 W 7th Ave Ste 1800, Anchorage, AK 99501 Phone: 907-269-7300 | |
Bryan Farthing, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3841 Piper St, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228 | |
Kimberley Turner, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1400 E 4th Ave, Anchorage, AK 99501 Phone: 907-269-4234 Fax: 907-269-4235 | |
Corinne Faye Olivera, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5005 Raspberry Rd, Building 9, Anchorage, AK 99502 Phone: 907-249-1276 Fax: 907-249-1145 | |
Mark Andrew Malzahn, P.A.-C. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4100 Lake Otis Pkwy, #302, Anchorage, AK 99508 Phone: 907-563-7072 Fax: 907-562-5742 | |
Mrs. Cynthia Jean Smith, PC-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2550 Denali St, Anchorage, AK 99503 Phone: 907-375-8787 | |
Even R Evanson, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 3841 Piper St, Suite T-100, Anchorage, AK 99508 Phone: 907-561-3211 Fax: 907-562-7547 |